h.kravchenko
Submits third-party assay reports on material purchased directly. Based in Rennes.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.84%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041682 | CJC-1295 with DAC | TFS | TFS-{CAT}-9675 | Nordanalyt | 2026-Q3 | 98.94 | 3.24 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041660 | Tirzepatide | FGP | FGP-2605-R8870 | Janoshik | 2026-Q2 | 97.91 | 6.52 | — | Laboratory-retained | 0 | PASS |
| AX-2025-020517 | MOTS-c | SSA | SSA-2501-M6154 | VendorInvestigate | 2025-Q1 | 98.21 | 3.21 | 103.0 | Buyer-sourced | 0 | PASS |
| AX-2025-018923 | CJC-1295 with DAC | TFS | TFS-{CAT}-9795 | Janoshik | 2025-Q1 | 99.31 | 3.07 | 90.8 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004293 | Retatrutide | QSC | QSC-2411-C7111 | VendorInvestigate | 2024-Q4 | 99.00 | 3.26 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005356 | MK-677 (Ibutamoren mesylate) | SIG | SIG-2404-6898 | PeptideMeter | 2024-Q3 | 98.74 | 3.36 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004727 | GHRP-6 | Homopeptide | HOMO-2407-T4218 | PeptideMeter | 2024-Q3 | 99.93 | 6.82 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004445 | Semaglutide | GSP | GSP-2405-W3331 | Janoshik | 2024-Q2 | 98.65 | 3.27 | — | Buyer-sourced | 0 | PASS |